Beyond Air (NASDAQ:XAIR) Stock Price Down 0.7% – Should You Sell?

Beyond Air, Inc. (NASDAQ:XAIR)’s share price fell 0.7% on Monday . The company traded as low as $0.40 and last traded at $0.4101. 212,844 shares were traded during trading, a decline of 12% from the average session volume of 242,644 shares. The stock had previously closed at $0.4128.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beyond Air in a research report on Friday, April 24th. D. Boral Capital reiterated a “buy” rating and set a $10.00 price target on shares of Beyond Air in a research report on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Beyond Air to a “sell” rating in a research report on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $10.00.

Beyond Air Price Performance

The business’s fifty day moving average price is $0.53 and its 200 day moving average price is $0.88. The company has a debt-to-equity ratio of 2.65, a current ratio of 5.12 and a quick ratio of 4.77. The stock has a market cap of $5.01 million, a P/E ratio of -0.07 and a beta of 0.26.

Institutional Investors Weigh In On Beyond Air

Hedge funds have recently made changes to their positions in the stock. Alpine Global Management LLC acquired a new stake in shares of Beyond Air in the 3rd quarter valued at approximately $25,000. Osaic Holdings Inc. boosted its stake in shares of Beyond Air by 26.4% in the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after purchasing an additional 34,000 shares in the last quarter. Alyeska Investment Group L.P. acquired a new stake in shares of Beyond Air in the 3rd quarter valued at approximately $1,753,000. Geode Capital Management LLC boosted its stake in shares of Beyond Air by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock valued at $144,000 after purchasing an additional 12,598 shares in the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of Beyond Air in the 3rd quarter valued at approximately $48,000. 31.50% of the stock is currently owned by institutional investors and hedge funds.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.